1-3 of 3
Mona-Elisabeth R. Revheim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Krd Consolidation Abrogates Poor Prognosis of FDG PET/CT Positivity after ASCT: Results from a Phase II Study (CONPET)

Jakob Nordberg Nørgaard, Anna Lysén, Galina Tsykunova, Annette Vangsted, Cristina João, Nora Remen, Lene Kongsgaard Nielsen, Caroline Stokke, James P Connelly, Mona-Elisabeth R. Revheim, Fredrik Schjesvold
Journal: Blood
Blood (2024) 144 (Supplement 1): 4745.
https://doi.org/10.1182/blood-2024-198925
Published: 2024
Journal Articles

Carfilzomib-Lenalidomide-Dexamethasone Consolidation in Myeloma Patients with a Positive FDG PET/CT after Upfront Autologous Stem Cell Transplantation: A Phase II Study (CONPET)

Jakob Nordberg Nørgaard, Niels Abildgaard, Anna Lysén, Galina Tsykunova, Annette Juul Vangsted, Cristina João, Nora Remen, James P Connelly, Mona-Elisabeth R. Revheim, Fredrik H. Schjesvold
Journal: Blood
Blood (2021) 138 (Supplement 1): 3939.
https://doi.org/10.1182/blood-2021-147240
Published: 2021
Journal Articles

Krd Consolidation in Myeloma Patients with a Positive PET-CT after Standard First Line Treatment: A Phase II Study (CONPET)

Jakob Nordberg Nørgaard, MD, Niels Abildgaard, MD, Anna Lysén, MSc, Mona-Elisabeth R Revheim, MD PhD, James P Connelly, MD PhD, Fredrik H. Schjesvold, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3172.
https://doi.org/10.1182/blood-2019-125523
Published: 2019